Medicare Enrolled
Dr. Billy Nordyke, D.O.
Family Medicine · Wyandotte, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nordyke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nordyke?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nordyke
Dr. Billy Nordyke is a family medicine specialist in Wyandotte, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nordyke performed 1,498 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nordyke received a total of $4,708 from 36 pharmaceutical and/or device companies across 250 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nordyke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in MI
$4,708 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,498
Medicare services
Top 10% in MI for family medicine
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
264 | $0 | $3 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
204 | $1 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $61 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
153 | $86 | $204 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
100 | $0 | $3 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
77 | $2 | $4 |
| Annual alcohol misuse screening, 5 to 15 minutes | 76 | $18 | $26 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
69 | $74 | $140 |
| Annual depression screening | 67 | $18 | $34 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
52 | $130 | $252 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
46 | $31 | $42 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
40 | $1 | $5 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
28 | $10 | $20 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
28 | $72 | $100 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
27 | $50 | $82 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
20 | $186 | $432 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
17 | $31 | $40 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
14 | $16 | $24 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
14 | $167 | $309 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
13 | $16 | $25 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
13 | $283 | $312 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
12 | $22 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,708
Total received (2018-2024)
Avg $673/year across 7 years
Top 9% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
250
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,082
2023
$1,111
2022
$1,513
2021
$764
2020
$185
2019
$42
2018
$12
Payments by company (2024)
Otsuka America Pharmaceutical, Inc.
$208
GlaxoSmithKline, LLC.
$178
Ardelyx, Inc.
$153
Lundbeck LLC
$89
Amgen Inc.
$82
PFIZER INC.
$75
AstraZeneca Pharmaceuticals LP
$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$63
ABBVIE INC.
$55
Exact Sciences Corporation
$33
Xeris Pharmaceuticals, Inc.
$21
Novo Nordisk Inc
$18
ABIOMED
$14
Supernus Pharmaceuticals, Inc.
$14
Axsome Therapeutics, Inc.
$14
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$753
AstraZeneca Pharmaceuticals LP
$491
GlaxoSmithKline, LLC.
$447
Otsuka America Pharmaceutical, Inc.
$395
Amgen Inc.
$380
ITI, Inc.
$244
AbbVie Inc.
$234
Supernus Pharmaceuticals, Inc.
$167
PFIZER INC.
$163
Ardelyx, Inc.
$153
Lundbeck LLC
$132
SANOFI PASTEUR INC.
$90
IMPEL PHARMACEUTICALS INC.
$84
Ultragenyx Pharmaceutical Inc.
$83
Exact Sciences Corporation
$73
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$72
Axsome Therapeutics, Inc.
$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$63
Biohaven Pharmaceutical Holding Company Ltd.
$62
Teva Pharmaceuticals USA, Inc.
$56
Pulmonx Corporation
$53
Cardiovascular Systems Inc.
$50
Circassia Pharmaceuticals Inc
$50
SCYNEXIS, Inc.
$45
Xeris Pharmaceuticals, Inc.
$40
Shield Therapeutics Inc
$36
Novo Nordisk Inc
$35
Dexcom, Inc.
$34
ABIOMED
$27
Qiagen, LLC
$26
Dermavant Sciences, Inc.
$19
Novartis Pharmaceuticals Corporation
$18
Biohaven Pharmaceuticals, Inc.
$17
Lilly USA, LLC
$17
Amarin Pharma Inc.
$15
Hologic Sales and Service, LLC
$13
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACCRUFER · AIRSUPRA · AJOVY · ANORO ELLIPTA · APTIMA · AREXVY · Aimovig · Auvelity · BREZTRI · CAPLYTA · COMIRNATY · CREON · Cologuard Collection Kit · Crysvita · Cryvista · DUAKLIR PRESSAIR · Dexcom G6 Transmitter · Diamondback Peripheral · EMGALITY · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · Impella · KRYSTEXXA · LEQVIO · LINZESS · LYRICA · NURTEC ODT · Otezla · PAXLOVID · PREMARIN · Peripheral Orbital Atherectomy System · QELBREE · QUADRACEL · QUANTIFERON-TB GOLD PLUS · QULIPTA · Qelbree · REXULTI · SAPHNELO · SHINGRIX · SYMBICORT · TRELEGY ELLIPTA · TROKENDI XR · TUDORZA PRESSAIR · Trudhesa · UBRELVY · VRAYLAR · VTAMA · Vascepa · Wegovy · XIFAXAN · ZEPHYR DELIVERY CATHETER
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
1,355
County median income
$59,521
Nearest hospital to ZIP centroid (approximate)
WYANDOTTE HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nordyke is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nordyke experienced with ketorolac injection, per 15 mg?
Based on Medicare claims data, Dr. Nordyke performed 264 ketorolac injection, per 15 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nordyke receive payments from pharmaceutical companies?
Yes. Dr. Nordyke received a total of $4,708 from 36 companies across 250 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nordyke's costs compare to other family medicine physicians in Wyandotte?
Dr. Nordyke's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nordyke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Wyandotte
Browse family medicine physicians in Wyandotte ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MI
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MI
Which MI family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology